KalVista Pharmaceuticals, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Option Exercise | 15,625 | — | — | 431,814 | Dec 8, 2025 |
| Piekos Brian | Chief Financial Officer | Option Exercise | 15,000 | — | — | 15,000 | Nov 24, 2025 |
| Sweeny Nicole | Chief Commercial Officer | Option Exercise | 6,250 | — | — | 38,541 | Nov 22, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER | Option Exercise | 3,125 | — | — | 227,839 | Nov 21, 2025 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | Option Exercise | 5,000 | — | — | 137,127 | Nov 21, 2025 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sale | 10,940 | $13.45 | $147,143 | 416,189 | Nov 21, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER | Option Exercise | 87,390 | — | — | 220,964 | Nov 20, 2025 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | Option Exercise | 6,447 | — | — | 128,952 | Nov 18, 2025 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sale | 4,466 | $14.48 | $64,668 | 403,879 | Nov 17, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sale | 2,683 | $14.48 | $38,850 | 133,574 | Nov 17, 2025 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sale | 3,328 | $11.55 | $38,438 | 398,981 | Nov 11, 2025 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Option Exercise | 15,625 | — | — | 402,483 | Sep 8, 2025 |
| Sweeny Nicole | Chief Commercial Officer | Option Exercise | 5,000 | — | — | 33,771 | Aug 25, 2025 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | Option Exercise | 5,000 | — | — | 124,841 | Aug 25, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sale | 1,954 | $13.42 | $26,223 | 132,052 | Aug 22, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER | Option Exercise | 3,750 | — | — | 133,243 | Aug 22, 2025 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Option Exercise | 23,250 | — | — | 397,798 | Aug 22, 2025 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | Option Exercise | 6,250 | — | — | 122,783 | Aug 22, 2025 |
| Sweeny Nicole | Chief Commercial Officer | Sale | 1,864 | $13.22 | $24,642 | 28,771 | Aug 21, 2025 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | Option Exercise | 6,446 | — | — | 119,472 | Aug 18, 2025 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Option Exercise | 9,362 | — | — | 378,957 | Aug 18, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sale | 2,649 | $13.19 | $34,940 | 129,493 | Aug 17, 2025 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sale | 32,979 | $15.69 | $517,441 | 369,595 | Jul 8, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sale | 30,250 | $15.69 | $474,623 | 127,939 | Jul 8, 2025 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sale | 7,169 | $14.50 | $103,951 | 315,074 | Jun 6, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER | Option Exercise | 3,125 | — | — | 100,115 | May 23, 2025 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | Sale | 2,146 | $11.31 | $24,271 | 113,026 | May 22, 2025 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | Option Exercise | 6,250 | — | — | 112,861 | May 22, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER | Option Exercise | 3,750 | — | — | 99,307 | May 22, 2025 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Option Exercise | 23,250 | — | — | 316,617 | May 22, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sale | 2,600 | $11.84 | $30,784 | 95,557 | May 17, 2025 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sale | 3,808 | $11.84 | $45,087 | 293,367 | May 17, 2025 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | Sale | 2,776 | $11.84 | $32,868 | 106,611 | May 17, 2025 |
| Venrock Healthcare Capital Partners EG, L.P. | — | Purchase | 25,000 | $9.42 | $235,500 | 5,303,985 | Apr 9, 2025 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Option Exercise | 15,625 | — | — | 294,480 | Mar 7, 2025 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | Option Exercise | 5,000 | — | — | 105,334 | Feb 24, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sale | 1,918 | $10.02 | $19,218 | 93,952 | Feb 22, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sale | 2,601 | $9.82 | $25,542 | 92,745 | Feb 17, 2025 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | Sale | 3,125 | $9.82 | $30,688 | 100,334 | Feb 17, 2025 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sale | 5,104 | $9.82 | $50,121 | 278,855 | Feb 17, 2025 |
| VHCP Management EG, LLC | — | Purchase | 100,000 | $9.23 | $923,000 | 5,217,285 | Feb 13, 2025 |
| Venrock Healthcare Capital Partners III, L.P. | — | Purchase | 4,137 | $9.14 | $37,812 | 5,090,582 | Feb 7, 2025 |
| VHCP Management III, LLC | — | Purchase | 14,562 | $9.22 | $134,262 | 5,012,796 | Jan 31, 2025 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sale | 7,627 | $9.75 | $74,363 | 274,596 | Dec 6, 2024 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | Option Exercise | 5,000 | — | — | 99,199 | Nov 26, 2024 |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER | Option Exercise | 3,125 | — | — | 93,105 | Nov 26, 2024 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Option Exercise | 30,198 | — | — | 280,998 | Nov 18, 2024 |
| Yea Christopher | CHIEF DEVELOPMENT OFFICER | Sale | 7,192 | $9.26 | $66,598 | 89,980 | Nov 17, 2024 |
| Audhya Paul K. | CHIEF MEDICAL OFFICER | Sale | 8,077 | $9.26 | $74,793 | 94,199 | Nov 17, 2024 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OFFICER | Sale | 7,352 | $12.19 | $89,621 | 250,800 | Sep 6, 2024 |